Evidence map›Paper›PMID 42308237›Full record

ArticlePLoS genetics2026

Ultra-fast genetic colocalisation across millions of association signals.

Mihkel Jesse, Ago-Erik Riet, Kaur Alasoo

Abstract read
In one paragraph

Article in PLoS genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mihkel JesseInstitute of Computer Science, University of Tartu, Tartu, Estonia.ORCID https://orcid.org/0009-0008-6108-411X
Ago-Erik RietInstitute of Mathematics and Statistics, University of Tartu, Tartu, Estonia.ORCID https://orcid.org/0000-0002-8310-6809
Kaur AlasooInstitute of Computer Science, University of Tartu, Tartu, Estonia.ORCID https://orcid.org/0000-0002-1761-8881

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Co localisation is a powerful approach to assess if two genetic association signals are likely to share a causal variant. However, association analyses in large bio banks and molecular quantitative trait loci (molmol) studies now routinely identify millions of association signals across thousands of traits, making it infeasible to test for colocalization between all pairs of signals. Here we introduce gpu-coloc, a GPU-accelerated re-implementation of the coloc algorithm that combines efficient data storage with parallelisation to achieve a 1000-fold speed increase while maintaining near-identical results. As a result, the run time of gpu-coloc now approaches the colocalisation posterior probability (CLPP) method, a competing method that only uses information from fine mapped credible sets to detect colocalisations. Using summary statistics from UK Biobank, FinnGen, and eQTL Catalogue, we demonstrate that gpu-coloc and CLPP detect highly concordant results, especially when restricting the analysis to confidently fine mapped signals. We introduce the colocalisation collider metric to quantify spurious colocalisations in large-scale colocalisation graphs and use it to choose decision thresholds that provide a reasonable trade-off between sensitivity and specificity. Finally, we demonstrate how gpu-coloc can also be applied to marginal GWAS summary statistics from studies that lack fine mapping, where it is still able to recover molQTL colocalisations for ~80% of the GWAS loci. Our efficient software and comprehensive analyses provide practical guidelines for future large-scale colocalisation analyses.

Indexed as

Genome-Wide Association StudyQuantitative Trait LociAlgorithmsHumansParallel AlgorithmsPolymorphism, Single NucleotideSoftware

Identifiers

PMID42308237
PMCPMC13289940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.